Circulation. 2002;105:93-98
doi: 10.1161/hc0102.101442
doi: 10.1161/hc0102.101442
(Circulation. 2002;105:93.)
© 2002 American Heart Association, Inc.
Basic Science Reports |
Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart
From the Department of Medicine, Division of Cardiology, Johns Hopkins School of Medicine (C.T., P.D.K.), and Osiris Therapeutics, Inc (M.F.P.), Baltimore, Md; and the Powell Gene Therapy Center, Departments of Pediatrics, Molecular Genetics, and Microbiology, University of Florida School of Medicine, Gainesville, Fla (K.S.C., B.J.B.).
Correspondence to Mark Pittenger, PhD, Osiris Therapeutics Inc, 2001 Aliceanna St, Baltimore, MD 21231. E-mail mpittenger{at}osiristx.com
Background— Cellular cardiomyoplasty has been proposed as an alternative strategy for augmenting the function of diseased myocardium. We investigated the potential of human mesenchymal stem cells (hMSCs) from adult bone marrow to undergo myogenic differentiation once transplanted into the adult murine myocardium.
Methods and Results— A small bone marrow aspirate was taken from the iliac crest of healthy human volunteers, and hMSCs were isolated as previously described. The stem cells, labeled with lacZ, were injected into the left ventricle of CB17 SCID/beige adult mice. At 4 days after injection, none of the engrafted hMSCs expressed myogenic markers. A limited number of cells survived past 1 week and over time morphologically resembled the surrounding host cardiomyocytes. Immunohistochemistry revealed de novo expression of desmin, ß-myosin heavy chain, 
-actinin, cardiac troponin T, and phospholamban at levels comparable to those of the host cardiomyocytes; sarcomeric organization of the contractile proteins was observed. In comparison, neither cardiac troponin T nor phospholamban was detected in the myotubes formed in vitro by MyoD-transduced hMSCs.
Conclusions— The purified hMSCs from adult bone marrow engrafted in the myocardium appeared to differentiate into cardiomyocytes. The persistence of the engrafted hMSCs and their in situ differentiation in the heart may represent the basis for using these adult stem cells for cellular cardiomyoplasty.
Key Words: stem cells • genes • myocytes • heart failure
This article has been cited by other articles:
 |
|
 |
|
  J. L. Herrmann, A. M. Abarbanell, B. R. Weil, Y. Wang, M. Wang, J. Tan, and D. R. Meldrum Cell-based therapy for ischemic heart disease: a clinical update. Ann. Thorac. Surg., November 1, 2009; 88(5): 1714 - 1722. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Higuchi, M. Anton, A. Saraste, K. Dumler, J. Pelisek, S. G. Nekolla, F. M. Bengel, and M. Schwaiger Reporter Gene PET for Monitoring Survival of Transplanted Endothelial Progenitor Cells in the Rat Heart After Pretreatment with VEGF and Atorvastatin J. Nucl. Med., November 1, 2009; 50(11): 1881 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Fan, C. Lin, S. Zhuo, L. Chen, N. Liu, Y. Luo, J. Fang, Z. Huang, Y. Lin, and J. Chen Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction Eur J Heart Fail, November 1, 2009; 11(11): 1023 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Gersh, R. D. Simari, A. Behfar, C. M. Terzic, and A. Terzic Cardiac Cell Repair Therapy: A Clinical Perspective Mayo Clin. Proc., October 1, 2009; 84(10): 876 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Mathieu, J. Bartunek, B. El Oumeiri, K. Touihri, I. Hadad, P. Thoma, T. Metens, A. M. da Costa, M. Mahmoudabady, D. Egrise, et al. Cell therapy with autologous bone marrow mononuclear stem cells is associated with superior cardiac recovery compared with use of nonmodified mesenchymal stem cells in a canine model of chronic myocardial infarction J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 646 - 653. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Quevedo, K. E. Hatzistergos, B. N. Oskouei, G. S. Feigenbaum, J. E. Rodriguez, D. Valdes, P. M. Pattany, J. P. Zambrano, Q. Hu, I. McNiece, et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity PNAS, August 18, 2009; 106(33): 14022 - 14027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. D. Boudoulas and A. K. Hatzopoulos Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease Dis. Model. Mech., July 1, 2009; 2(7-8): 344 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Stappenbeck and H. Miyoshi The Role of Stromal Stem Cells in Tissue Regeneration and Wound Repair Science, June 26, 2009; 324(5935): 1666 - 1669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang, W. Ge, J. Arp, R. Zassoko, W. Liu, T. E. Ichim, J. Jiang, A. M. Jevnikar, and B. Garcia Free Bone Graft Attenuates Acute Rejection and in Combination with Cyclosporin A Leads to Indefinite Cardiac Allograft Survival J. Immunol., May 15, 2009; 182(10): 5970 - 5981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P Sieveking and M. K. Ng Cell therapies for therapeutic angiogenesis: back to the bench Vascular Medicine, May 1, 2009; 14(2): 153 - 166. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Wisel, M. Khan, M. L. Kuppusamy, I. K. Mohan, S. M. Chacko, B. K. Rivera, B. C. Sun, K. Hideg, and P. Kuppusamy Pharmacological Preconditioning of Mesenchymal Stem Cells with Trimetazidine (1-[2,3,4-Trimethoxybenzyl]piperazine) Protects Hypoxic Cells against Oxidative Stress and Enhances Recovery of Myocardial Function in Infarcted Heart through Bcl-2 Expression J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 543 - 550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Bagi and G. Kaley Where Have All the Stem Cells Gone? Circ. Res., February 13, 2009; 104(3): 280 - 281. [Full Text] [PDF]
|
|
|
|
|
|
C. Toma, W. R. Wagner, S. Bowry, A. Schwartz, and F. Villanueva Fate Of Culture-Expanded Mesenchymal Stem Cells in The Microvasculature: In Vivo Observations of Cell Kinetics Circ. Res., February 13, 2009; 104(3): 398 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Jin, S. I. Jeong, Y. M. Shin, K. S. Lim, H. s. Shin, Y. M. Lee, H. C. Koh, and K.-S. Kim Transplantation of mesenchymal stem cells within a poly(lactide-co-{varepsilon}-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model Eur J Heart Fail, February 1, 2009; 11(2): 147 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-E. Strauer, G. Ott, C. M. Schannwell, and M. Brehm Bone marrow cells to improve ventricular function Heart, January 15, 2009; 95(2): 98 - 99. [Full Text] [PDF]
|
|
|
|
|
|
A Ghodsizad, M Niehaus, G Kogler, U Martin, P Wernet, C Bara, N Khaladj, A Loos, M Makoui, J Thiele, et al. Transplanted human cord blood-derived unrestricted somatic stem cells improve left-ventricular function and prevent left-ventricular dilation and scar formation after acute myocardial infarction Heart, January 1, 2009; 95(1): 27 - 35. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Alfaro, M. Pagni, A. Vincent, J. Atkinson, M. F. Hill, J. Cates, J. M. Davidson, J. Rottman, E. Lee, and P. P. Young The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair PNAS, November 25, 2008; 105(47): 18366 - 18371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Perez-Ilzarbe, O. Agbulut, B. Pelacho, C. Ciorba, E. S. Jose-Eneriz, M. Desnos, A. A. Hagege, P. Aranda, E. J. Andreu, P. Menasche, et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium Eur J Heart Fail, November 1, 2008; 10(11): 1065 - 1072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Zeng, H. Chen, C. Zhu, X. Ren, G. Lin, and F. Cao Effects of combined mesenchymal stem cells and heme oxygenase-1 therapy on cardiac performance Eur. J. Cardiothorac. Surg., October 1, 2008; 34(4): 850 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Carr, D. J. Stuckey, L. Tatton, D. J. Tyler, S. J. M. Hale, D. Sweeney, J. E. Schneider, E. Martin-Rendon, G. K. Radda, S. E. Harding, et al. Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H533 - H542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Ward and D. J. Stewart Erythropoietin and mesenchymal stromal cells in angiogenesis and myocardial regeneration: one plus one equals three? Cardiovasc Res, August 1, 2008; 79(3): 357 - 359. [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Rebelatto, A. M. Aguiar, M. P. Moretao, A. C. Senegaglia, P. Hansen, F. Barchiki, J. Oliveira, J. Martins, C. Kuligovski, F. Mansur, et al. Dissimilar Differentiation of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, and Adipose Tissue Experimental Biology and Medicine, July 1, 2008; 233(7): 901 - 913. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Izadpanah, D. Kaushal, C. Kriedt, F. Tsien, B. Patel, J. Dufour, and B. A. Bunnell Long-term In vitro Expansion Alters the Biology of Adult Mesenchymal Stem Cells Cancer Res., June 1, 2008; 68(11): 4229 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Hu, S. P. Yu, J. L. Fraser, Z. Lu, M. E. Ogle, J.-A. Wang, and L. Wei Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 799 - 808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dimmeler, J. Burchfield, and A. M. Zeiher Cell-Based Therapy of Myocardial Infarction Arterioscler Thromb Vasc Biol, February 1, 2008; 28(2): 208 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kubo, T.-S. Li, R. Suzuki, B. Shirasawa, N. Morikage, M. Ohshima, S.-L. Qin, and K. Hamano Hypoxic preconditioning increases survival and angiogenic potency of peripheral blood mononuclear cells via oxidative stress resistance Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H590 - H595. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Wang, C.-H. Chen, W.-W. Lin, S.-M. Hwang, P. C.H. Hsieh, P.-H. Lai, Y.-C. Yeh, Y. Chang, and H.-W. Sung Direct intramyocardial injection of mesenchymal stem cell sheet fragments improves cardiac functions after infarction Cardiovasc Res, February 1, 2008; 77(3): 515 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Shujia, H. K. Haider, N. M. Idris, G. Lu, and M. Ashraf Stable therapeutic effects of mesenchymal stem cell-based multiple gene delivery for cardiac repair Cardiovasc Res, February 1, 2008; 77(3): 525 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Au, L. M. Daheron, D. G. Duda, K. S. Cohen, J. A. Tyrrell, R. M. Lanning, D. Fukumura, D. T. Scadden, and R. K. Jain Differential in vivo potential of endothelial progenitor cells from human umbilical cord blood and adult peripheral blood to form functional long-lasting vessels Blood, February 1, 2008; 111(3): 1302 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Gallegos and R. M. Bolman III Stem Cell Induced Regeneration of Myocardium Card. Surg. Adult, January 1, 2008; 3(2008): 1657 - 1668. [Full Text]
|
|
|
|
|
|
Z. Pasha, Y. Wang, R. Sheikh, D. Zhang, T. Zhao, and M. Ashraf Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium Cardiovasc Res, January 1, 2008; 77(1): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Koyanagi, P. Bushoven, M. Iwasaki, C. Urbich, A. M. Zeiher, and S. Dimmeler Notch Signaling Contributes to the Expression of Cardiac Markers in Human Circulating Progenitor Cells Circ. Res., November 26, 2007; 101(11): 1139 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Tao, C.-P. Lau, H.-F. Tse, and G.-R. Li Functional ion channels in mouse bone marrow mesenchymal stem cells Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1561 - C1567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Rajasingh, E. Bord, H. Hamada, E. Lambers, G. Qin, D. W. Losordo, and R. Kishore STAT3-Dependent Mouse Embryonic Stem Cell Differentiation Into Cardiomyocytes: Analysis of Molecular Signaling and Therapeutic Efficacy of Cardiomyocyte Precommitted mES Transplantation in a Mouse Model of Myocardial Infarction Circ. Res., October 26, 2007; 101(9): 910 - 918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, N. Mal, M. Kiedrowski, M. Chacko, A. T. Askari, Z. B. Popovic, O. N. Koc, and M. S. Penn SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction FASEB J, October 1, 2007; 21(12): 3197 - 3207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Feygin, A. Mansoor, P. Eckman, C. Swingen, and J. Zhang Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1772 - H1780. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Batten, N. A Rosenthal, and M. H Yacoub Immune response to stem cells and strategies to induce tolerance Phil Trans R Soc B, August 29, 2007; 362(1484): 1343 - 1356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Aupperle, J. Garbade, A. Schubert, M. Barten, S. Dhein, H.-A Schoon, and F.-W Mohr Effects of Autologous Stem Cells on Immunohistochemical Patterns and Gene Expression of Metalloproteinases and Their Tissue Inhibitors in Doxorubicin Cardiomyopathy in a Rabbit Model Vet. Pathol., July 1, 2007; 44(4): 494 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Penicka, O Lang, P Widimsky, P Kobylka, T Kozak, T Vanek, J Dvorak, J Tintera, and J Bartunek One-day kinetics of myocardial engraftment after intracoronary injection of bone marrow mononuclear cells in patients with acute and chronic myocardial infarction Heart, July 1, 2007; 93(7): 837 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Abdel-Latif, R. Bolli, I. M. Tleyjeh, V. M. Montori, E. C. Perin, C. A. Hornung, E. K. Zuba-Surma, M. Al-Mallah, and B. Dawn Adult Bone Marrow-Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis Arch Intern Med, May 28, 2007; 167(10): 989 - 997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ventura, S. Cantoni, F. Bianchi, V. Lionetti, C. Cavallini, I. Scarlata, L. Foroni, M. Maioli, L. Bonsi, F. Alviano, et al. Hyaluronan Mixed Esters of Butyric and Retinoic Acid Drive Cardiac and Endothelial Fate in Term Placenta Human Mesenchymal Stem Cells and Enhance Cardiac Repair in Infarcted Rat Hearts J. Biol. Chem., May 11, 2007; 282(19): 14243 - 14252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Hu, J. Wang, J. Chen, R. Luo, A. He, X. Xie, and J. Li Optimal temporal delivery of bone marrow mesenchymal stem cells in rats with myocardial infarction Eur. J. Cardiothorac. Surg., March 1, 2007; 31(3): 438 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zhou, P. D. Acton, and V. A. Ferrari Imaging Stem Cells Implanted in Infarcted Myocardium J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2094 - 2106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jiang, H. Kh. Haider, N. M. Idris, A. Salim, and M. Ashraf Supportive Interaction Between Cell Survival Signaling and Angiocompetent Factors Enhances Donor Cell Survival and Promotes Angiomyogenesis for Cardiac Repair Circ. Res., September 29, 2006; 99(7): 776 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nishimori, M. Deie, A. Kanaya, H. Exham, N. Adachi, and M. Ochi Repair of chronic osteochondral defects in the rat: A BONE MARROW-STIMULATING PROCEDURE ENHANCED BY CULTURED ALLOGENIC BONE MARROW MESENCHYMAL STROMAL CELLS J Bone Joint Surg Br, September 1, 2006; 88-B(9): 1236 - 1244. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Caspi and L. Gepstein Stem cells for myocardial repair Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E43 - E54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tang, Q. Xie, G. Pan, J. Wang, and M. Wang Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion. Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 353 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Boyle, S. P. Schulman, and J. M. Hare Stem Cell Therapy for Cardiac Repair: Ready for the Next Step Circulation, July 25, 2006; 114(4): 339 - 352. [Full Text] [PDF]
|
|
|
|
|
|
M. F. Berry, A. J. Engler, Y. J. Woo, T. J. Pirolli, L. T. Bish, V. Jayasankar, K. J. Morine, T. J. Gardner, D. E. Discher, and H. L. Sweeney Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2196 - H2203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Lim, Y. S. Kim, Y. Ahn, M. H. Jeong, M. H. Hong, S. Y. Joo, K. I. Nam, J. G. Cho, P. M. Kang, and J. C. Park The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model Cardiovasc Res, June 1, 2006; 70(3): 530 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Freyman, G. Polin, H. Osman, J. Crary, M. Lu, L. Cheng, M. Palasis, and R. L. Wilensky A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction Eur. Heart J., May 1, 2006; 27(9): 1114 - 1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Chang, L. Tung, R. B. Sekar, C. Y. Chang, J. Cysyk, P. Dong, E. Marban, and M. R. Abraham Proarrhythmic Potential of Mesenchymal Stem Cell Transplantation Revealed in an In Vitro Coculture Model Circulation, April 18, 2006; 113(15): 1832 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Gavira, J. Herreros, A. Perez, M. J. Garcia-Velloso, J. Barba, F. Martin-Herrero, C. Canizo, A. Martin-Arnau, J. M. Marti-Climent, M. Hernandez, et al. Autologous skeletal myoblast transplantation in patients with nonacute myocardial infarction: 1-year follow-up J. Thorac. Cardiovasc. Surg., April 1, 2006; 131(4): 799 - 804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gnecchi, H. He, N. Noiseux, O. D. Liang, L. Zhang, F. Morello, H. Mu, L. G. Melo, R. E. Pratt, J. S. Ingwall, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement FASEB J, April 1, 2006; 20(6): 661 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L.M.A. Beeres, J. J. Bax, P. Dibbets, M. P.M. Stokkel, K. Zeppenfeld, W. E. Fibbe, E. E. van der Wall, M. J. Schalij, and D. E. Atsma Effect of Intramyocardial Injection of Autologous Bone Marrow-Derived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia J. Nucl. Med., April 1, 2006; 47(4): 574 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wang, Q. Hu, A. Mansoor, J. Lee, Z. Wang, T. Lee, A. H. L. From, and J. Zhang Bioenergetic and functional consequences of stem cell-based VEGF delivery in pressure-overloaded swine hearts Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1393 - H1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Stagg, S. Pommey, N. Eliopoulos, and J. Galipeau Interferon-{gamma}-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell Blood, March 15, 2006; 107(6): 2570 - 2577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Spaggiari, A. Capobianco, S. Becchetti, M. C. Mingari, and L. Moretta Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation Blood, February 15, 2006; 107(4): 1484 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Raikwar, T. Mueller, and N. Zavazava Strategies for Developing Therapeutic Application of Human Embryonic Stem Cells Physiology, February 1, 2006; 21(1): 19 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Minguell and A. Erices Mesenchymal Stem Cells and the Treatment of Cardiac Disease Experimental Biology and Medicine, January 1, 2006; 231(1): 39 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Abrahamson and B. M. Steenhard Renal Therapy by Stem Cells: Outsource or In-House? J. Am. Soc. Nephrol., January 1, 2006; 17(1): 12 - 14. [Full Text] [PDF]
|
|
|
|
|
|
J. Andrade, J. T. Lam, M. Zamora, C. Huang, D. Franco, N. Sevilla, P. J. Gruber, J. T. Lu, and P. Ruiz-Lozano Predominant fusion of bone marrow-derived cardiomyocytes Cardiovasc Res, December 1, 2005; 68(3): 387 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Murry, L. J. Field, and P. Menasche Cell-Based Cardiac Repair: Reflections at the 10-Year Point Circulation, November 15, 2005; 112(20): 3174 - 3183. [Full Text] [PDF]
|
|
|
|
|
|
Y. L. Tang, Y. Tang, Y. C. Zhang, K. Qian, L. Shen, and M. I. Phillips Improved Graft Mesenchymal Stem Cell Survival in Ischemic Heart With a Hypoxia-Regulated Heme Oxygenase-1 Vector J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1339 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. J. Dzau, M. Gnecchi, and A. S. Pachori Enhancing Stem Cell Therapy Through Genetic Modification J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1351 - 1353. [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Makkar, M. J. Price, M. Lill, M. Frantzen, K. Takizawa, T. Kleisli, J. Zheng, S. Kar, R. McClelan, T. Miyamota, et al. Intramyocardial Injection of Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Without Immunosuppression Preserves Cardiac Function in a Porcine Model of Myocardial Infarction Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2005; 10(4): 225 - 233. [Abstract] [PDF]
|
|
|
|
|
|
D. L. Kraitchman, M. Tatsumi, W. D. Gilson, T. Ishimori, D. Kedziorek, P. Walczak, W. P. Segars, H. H. Chen, D. Fritzges, I. Izbudak, et al. Dynamic Imaging of Allogeneic Mesenchymal Stem Cells Trafficking to Myocardial Infarction Circulation, September 6, 2005; 112(10): 1451 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Laflamme, J. Gold, C. Xu, M. Hassanipour, E. Rosler, S. Police, V. Muskheli, and C. E. Murry Formation of Human Myocardium in the Rat Heart from Human Embryonic Stem Cells Am. J. Pathol., September 1, 2005; 167(3): 663 - 671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, Y. Miyahara, T. Fujii, M. Uematsu, H. Ohgushi, M. Yamagishi, et al. Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy Circulation, August 23, 2005; 112(8): 1128 - 1135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Siepe, C. Heilmann, P. von Samson, P. Menasche, and F. Beyersdorf Stem cell research and cell transplantation for myocardial regeneration Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 318 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rojas, J. Xu, C. R. Woods, A. L. Mora, W. Spears, J. Roman, and K. L. Brigham Bone Marrow-Derived Mesenchymal Stem Cells in Repair of the Injured Lung Am. J. Respir. Cell Mol. Biol., August 1, 2005; 33(2): 145 - 152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ventura Forced myocardin expression primes cardiac and smooth muscle transcription patterning in human mesenchymal stem cells Cardiovasc Res, August 1, 2005; 67(2): 182 - 183. [Full Text] [PDF]
|
|
|
|
|
|
K. C. Wollert and H. Drexler Mesenchymal Stem Cells for Myocardial Infarction: Promises and Pitfalls Circulation, July 12, 2005; 112(2): 151 - 153. [Full Text] [PDF]
|
|
|
|
|
|
H. K. Haider and M. Ashraf Bone marrow stem cell transplantation for cardiac repair Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2557 - H2567. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Matsumoto, T. Omura, M. Yoshiyama, T. Hayashi, S. Inamoto, K.-R. Koh, K. Ohta, Y. Izumi, Y. Nakamura, K. Akioka, et al. Vascular Endothelial Growth Factor-Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction Arterioscler Thromb Vasc Biol, June 1, 2005; 25(6): 1168 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Riviere, F. P. Boudghene, F. Gazeau, J. Roger, J.-N. Pons, J.-P. Laissy, E. Allaire, J.-B. Michel, D. Letourneur, and J.-F. Deux Iron Oxide Nanoparticle-labeled Rat Smooth Muscle Cells: Cardiac MR Imaging for Cell Graft Monitoring and Quantitation Radiology, June 1, 2005; 235(3): 959 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hofmann, K. C. Wollert, G. P. Meyer, A. Menke, L. Arseniev, B. Hertenstein, A. Ganser, W. H. Knapp, and H. Drexler Monitoring of Bone Marrow Cell Homing Into the Infarcted Human Myocardium Circulation, May 3, 2005; 111(17): 2198 - 2202. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L Weissberg and A. Qasim Stem cell therapy for myocardial repair Heart, May 1, 2005; 91(5): 696 - 702. [Full Text] [PDF]
|
|
|
|
|
|
S. Aggarwal and M. F. Pittenger Human mesenchymal stem cells modulate allogeneic immune cell responses Blood, February 15, 2005; 105(4): 1815 - 1822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Wollert and H. Drexler Clinical Applications of Stem Cells for the Heart Circ. Res., February 4, 2005; 96(2): 151 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Davani, F. Deschaseaux, D. Chalmers, P. Tiberghien, and J.-P. Kantelip Can stem cells mend a broken heart? Cardiovasc Res, February 1, 2005; 65(2): 305 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. V. Silva, S. Litovsky, J. A.R. Assad, A. L.S. Sousa, B. J. Martin, D. Vela, S. C. Coulter, J. Lin, J. Ober, W. K. Vaughn, et al. Mesenchymal Stem Cells Differentiate into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model Circulation, January 18, 2005; 111(2): 150 - 156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Rastan, T. Walther, M. Kostelka, J. Garbade, A. Schubert, A. Stein, S. Dhein, and F. W. Mohr Morphological, electrophysiological and coupling characteristics of bone marrow-derived mononuclear cells--an in vitro-model Eur. J. Cardiothorac. Surg., January 1, 2005; 27(1): 104 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Deten, H. C. Volz, S. Clamors, S. Leiblein, W. Briest, G. Marx, and H.-G. Zimmer Hematopoietic stem cells do not repair the infarcted mouse heart Cardiovasc Res, January 1, 2005; 65(1): 52 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Dainiak and R C Ricks The evolving role of haematopoietic cell transplantation in radiation injury: potentials and limitations Br. J. Radiol., January 1, 2005; Supplement_27(1): 169 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagaya, T. Fujii, T. Iwase, H. Ohgushi, T. Itoh, M. Uematsu, M. Yamagishi, H. Mori, K. Kangawa, and S. Kitamura Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2670 - H2676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawada, J. Fujita, K. Kinjo, Y. Matsuzaki, M. Tsuma, H. Miyatake, Y. Muguruma, K. Tsuboi, Y. Itabashi, Y. Ikeda, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction Blood, December 1, 2004; 104(12): 3581 - 3587. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Anjos-Afonso, E. K. Siapati, and D. Bonnet In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions J. Cell Sci., November 1, 2004; 117(23): 5655 - 5664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.G Melo, M Gnecchi, A.S Pachori, K Wang, and V.J Dzau Gene- and cell-based therapies for cardiovascular diseases: current status and future directions Eur. Heart J. Suppl., September 1, 2004; 6(suppl_E): E24 - E35. [Abstract] [Full Text]
|
|
|
|
|
|
J. Liu, Q. Hu, Z. Wang, C. Xu, X. Wang, G. Gong, A. Mansoor, J. Lee, M. Hou, L. Zeng, et al. Autologous stem cell transplantation for myocardial repair Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H501 - H511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Pittenger and B. J. Martin Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics Circ. Res., July 9, 2004; 95(1): 9 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xu, X. Zhang, H. Qian, W. Zhu, X. Sun, J. Hu, H. Zhou, and Y. Chen Mesenchymal Stem Cells from Adult Human Bone Marrow Differentiate into a Cardiomyocyte Phenotype In Vitro Experimental Biology and Medicine, July 1, 2004; 229(7): 623 - 631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Honold, B. Assmus, R. Lehman, A. M. Zeiher, and S. Dimmeler Stem cell therapy of cardiac disease: an update Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1673 - 1677. [Full Text] [PDF]
|
|